Transfer of miR-100 and miR-125b increases 3D growth and invasiveness in recipient cancer cells

被引:1
|
作者
Nelson, Hannah M. [1 ]
Qu, Shimian [1 ]
Huang, Liyu [1 ]
Shameer, Muhammad [1 ]
Corn, Kevin C. [2 ]
Chapman, Sydney N. [1 ]
Luthcke, Nicole L. [1 ]
Schuster, Sara A. [1 ]
Stamaris, Tellie D. [1 ]
Turnbull, Lauren A. [1 ]
Guy, Lucas L. [1 ]
Liu, Xiao [3 ]
Michell, Danielle L. [4 ]
Semler, Elizabeth M. [4 ]
Vickers, Kasey C. [4 ]
Liu, Qi [3 ]
Franklin, Jeffrey L. [5 ]
Weaver, Alissa M. [6 ]
Rafat, Marjan [2 ]
Coffey, Robert J. [7 ]
Patton, James G. [1 ]
机构
[1] Vanderbilt Univ, Dept Biol Sci, Lab James G Patton, 2325 Stevenson Ctr, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Dept Biomed Engn, Lab Marjan Rafat, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Biostat, Lab Qi Liu, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Lab Kasey C Vickers, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA
[6] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Lab Alissa M Weaver, Nashville, TN 37235 USA
[7] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA
关键词
miRNA; miR-100; miR-125b; colorectal cancer; cingulin; invasiveness; tight junctions; SET ENRICHMENT ANALYSIS; TIGHT JUNCTIONS; RNA; CINGULIN; RECOGNITION; BIOGENESIS; EXPRESSION; RESISTANCE; MICRORNAS; MIR-125B;
D O I
10.20517/evcna.2024.43
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aim: Extracellular communication via the transfer of vesicles and nanoparticles is now recognized to play an important role in tumor microenvironment interactions. Cancer cells upregulate and secrete abundant levels of miR-100 and miR-125b that can alter gene expression in donor and recipient cells. In this study, we sought to identify targets of miR-100 and miR-125b and conclusively demonstrate that microRNAs (miRNAs) can be functionally transferred from donor to recipient cells. Methods: To identify targets of miR-100 and miR-125b, , we used bioinformatic approaches comparing multiple colorectal cancer (CRC) cell lines, including knockout lines lacking one or both of these miRNAs. We also used spheroid and 3D growth conditions in collagen to test colony growth and invasiveness. We also used Transwell co-culture systems to demonstrate functional miRNA transfer. Results: From an initial list of 96 potential mRNA targets, we identified and tested 15 targets, with 8 showing significant downregulation in the presence of miR-100 and miR-125b. . Among these, cingulin (CGN) and protein tyrosine phosphatase receptor type-R (PTPRR) are downregulated in multiple cancers, consistent with regulation by increased levels of miR-100 and miR-125b. We also show that increased cellular levels of miR-100 and miR-125b enhance 3D growth and invasiveness in CRC and glioblastoma cell lines. Lastly, we demonstrate that extracellular transfer of miR-100 and miR-125b can silence both reporter and endogenous mRNA targets in recipient cells and also increase the invasiveness of recipient spheroid colonies when grown under 3D conditions in type I collagen. Conclusion: miR-100 and miR-125b target multiple mRNAs that can regulate 3D cell-autonomous growth and invasiveness. By extracellular transfer, miR-100 and miR-125b can also increase colony growth and invasiveness in recipient cells through non-cell-autonomous mechanisms.
引用
收藏
页码:497 / 516
页数:20
相关论文
共 50 条
  • [1] Characterizing invasiveness in CCCR cells: Role of miR-100, miR-125b and EVs
    Shameer, Muhammad
    Nelson, Hannah M.
    Qu, Shimian
    Huang, Liyu
    Corn, Kevin C.
    Chapman, Sydney N.
    Luthcke, Nicole L.
    Schuster, Sara A.
    Stamaris, Tellie D.
    Turnbull, Lauren A.
    Guy, Lucas L.
    Liu, Xiao
    Michell, Danielle L.
    Semler, Elizabeth M.
    Vickers, Kasey C.
    Liu, Qi
    Franklin, Jeffrey L.
    Weaver, Alissa M.
    Rafat, Marjan
    Coffey, Robert J.
    Patton, James G.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (11)
  • [2] Decreased Expression of miR-125b and miR-100 in Oral Cancer Cells Contributes to Malignancy
    Henson, Brian J.
    Bhattacharjee, Samsiddhi
    O'Dee, Dawn M.
    Feingold, Eleanor
    Gollin, Susanne M.
    GENES CHROMOSOMES & CANCER, 2009, 48 (07): : 569 - 582
  • [3] miR-100 and miR-125b induce cetuximab resistance in CRC
    Hugh Thomas
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 691 - 691
  • [4] miR-100 and miR-125b induce cetuximab resistance in CRC
    Thomas, Hugh
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (12) : 691 - 691
  • [5] The expression of miR-125b and miR-100 in OSCC and their contribution to malignancy
    Henson, Brian
    Bhattacharjee, Samsiddhi
    O'Dee, Dawn
    Feingold, Eleanor
    Gollin, Susanne
    CANCER RESEARCH, 2009, 69
  • [6] TGF-Beta Induces miR-100 and miR-125b Promoting EMT and Stemness in Pancreatic Cancer
    Frampton, A. E.
    Ottaviani, S.
    Stebbing, J.
    Jiao, L. R.
    Castellano, L.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 6 - 6
  • [7] TGF-Beta Induces miR-100 and miR-125b Promoting EMT and Stemness in Pancreatic Cancer
    Frampton, A. E.
    Ottaviani, S.
    Stebbing, J.
    Jiao, L. R.
    Heeschen, C.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 21 - 21
  • [8] IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
    Lu, Yuanyuan
    Zhao, Xiaodi
    Liu, Qi
    Li, Cunxi
    Graves-Deal, Ramona
    Cao, Zheng
    Singh, Bhuminder
    Franklin, Jeffrey L.
    Wang, Jing
    Hu, Huaying
    Wei, Tianying
    Yang, Mingli
    Yeatman, Timothy J.
    Lee, Ethan
    Saito-Diaz, Kenyi
    Hinger, Scott
    Patton, James G.
    Chung, Christine H.
    Emmrich, Stephan
    Klusmann, Jan-Henning
    Fan, Daiming
    Coffey, Robert J.
    NATURE MEDICINE, 2017, 23 (11) : 1331 - +
  • [9] lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
    Yuanyuan Lu
    Xiaodi Zhao
    Qi Liu
    Cunxi Li
    Ramona Graves-Deal
    Zheng Cao
    Bhuminder Singh
    Jeffrey L Franklin
    Jing Wang
    Huaying Hu
    Tianying Wei
    Mingli Yang
    Timothy J Yeatman
    Ethan Lee
    Kenyi Saito-Diaz
    Scott Hinger
    James G Patton
    Christine H Chung
    Stephan Emmrich
    Jan-Henning Klusmann
    Daiming Fan
    Robert J Coffey
    Nature Medicine, 2017, 23 : 1331 - 1341
  • [10] Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
    Vergani, Elisabetta
    Di Guardo, Lorenza
    Dugo, Matteo
    Rigoletto, Sara
    Tragni, Gabrina
    Ruggeri, Roberta
    Perrone, Federica
    Tamborini, Elena
    Gloghini, Annunziata
    Arienti, Flavio
    Vergani, Barbara
    Deho, Paola
    De Cecco, Loris
    Vallacchi, Viviana
    Frati, Paola
    Shahaj, Eriomina
    Villa, Antonello
    Santinami, Mario
    De Braud, Filippo
    Rivoltini, Licia
    Rodolfo, Monica
    ONCOTARGET, 2016, 7 (04) : 4428 - 4441